ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1985

IL-1β Inhibits the Expression of Dickkopf-1, an Antagonist of the Wnt-β-Catenin Signaling Pathway: A Possible Role of Inflammasome in Dysregulation of Endochondral Ossification

Satoshi Yamasaki1, Yusuke Yoshida2, Katsuhiro Oi2, Tatsuomi Kuranobu2, Takaki Nojima2, Hiroaki Ida3 and Eiji Sugiyama4, 1Division of Rheumatology, Kurume University Medical Center, Fukuoka, Japan, 2Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan, 3Respiorogy, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan, 4Department of Clinical Immunology and Rheumatology, Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: arthritis and inflammasome activation, IL-1, IL-6, WNT Signaling

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoarthritis and Joint Biology – Basic Science Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Aberrant endochondral bone formation in the physis is a unique bone lesion in neonatal-onset multisystem inflammatory disease (NOMID), also called chronic infantile neurologic cutaneous articular (CINCA), the most severe of the cryopyrin-associated periodic syndrome (CAPS) diseases, which are interleukin 1β (IL-1β)-related monogenic autoinflammatory diseases. It is interesting that the pathological features of bone lesions in NOMID / CINCA are similar to those found in patients with fibrous dysplasia, a skeletal disease caused by the gain-of function mutation of the GNAS gene that leads to aberrant activation of the canonical Wnt signal. Since the importance of the Wnt signal in human skeletal development is evidenced by the existence of human diseases caused by abnormalities associated with Wnt receptors, we explored the potential role of IL-1β on the expression of WNT genes and the Wnt antagonist Dickkopf-1 (DKK1).

Methods: The expression of WNT2, 3, 4, 5A, 11 and DKK1 mRNA in fibroblast-like synoviocytes (FLS) was quantified by quantitative PCR. The concentration of DKK1 in supernatant from FLS was determined by ELISA. Additionally, we used TCF reporter transfected in U2OS cell, a cell line that does not express DKK1, to evaluate the activity of the canonical Wnt signal pathway in the presence or absence of the supernatant of cultured FLS treated with or without IL-1β. Recombinant WNT3A or Lithium chloride (LiCl) was used to activate Wnt signal. Anti-DKK1 antibodies were used to neutralize DKK1 in supernatant from FLS culture.

Results: The mRNA expression of both canonical and non-canonical WNT genes as well as DKK1 was detected in FLS. FLS secreted DKK1 comparable to bone marrow-derived mesenchymal stromal cell. The supernatant of cultured FLS suppressed the luciferase activity of the TCF reporter, and this effect was reduced by its pre-treatment with an anti-DKK1 antibody. Moreover, the supernatant from FLS cultures significantly suppressed the TCF activity induced by WNT3A or LiCl in a dose dependent manner. IL-1β induced WNT2 and 5A, whereas significantly reduced DKK1 in FLS. Furthermore, the supernatant of FLS cultured with IL-1β showed a reduced inhibitory effect on TCF activity compared with the supernatant of untreated FLS.

Conclusion: FLS suppress Wnt signal via DKK1 production, and that IL-1β reduce DKK1 production from the cells and, thereby, activation Wnt signal. Therefore, it is possible that the overproduction of IL-1β in patients with NOMID/CINCA aberrantly activates the Wnt signal and leads to abnormalities in cartilage and bone differentiation. Our data, consistently with a previous report about fibrous dysplasia, suggest that two distinct genetic mutations in two different diseases lead to similar abnormal activation of the Wnt signal, and, consequently, similar bone lesions.


Disclosure: S. Yamasaki, None; Y. Yoshida, None; K. Oi, None; T. Kuranobu, None; T. Nojima, None; H. Ida, None; E. Sugiyama, None.

To cite this abstract in AMA style:

Yamasaki S, Yoshida Y, Oi K, Kuranobu T, Nojima T, Ida H, Sugiyama E. IL-1β Inhibits the Expression of Dickkopf-1, an Antagonist of the Wnt-β-Catenin Signaling Pathway: A Possible Role of Inflammasome in Dysregulation of Endochondral Ossification [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/il-1%ce%b2-inhibits-the-expression-of-dickkopf-1-an-antagonist-of-the-wnt-%ce%b2-catenin-signaling-pathway-a-possible-role-of-inflammasome-in-dysregulation-of-endochondral-ossification/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-1%ce%b2-inhibits-the-expression-of-dickkopf-1-an-antagonist-of-the-wnt-%ce%b2-catenin-signaling-pathway-a-possible-role-of-inflammasome-in-dysregulation-of-endochondral-ossification/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology